Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionUS price erosion, shrinking COVID-19 play expose drug firms to earnings risks

    US price erosion, shrinking COVID-19 play expose drug firms to earnings risks

    The September quarter results show continuing pricing pressure in the US while COVID-19 vaccine and the drugs opportunity is reduced for several firms

    R. Sree Ram
    November 12, 2021 / 08:39 IST
    Aisle in a CVS pharmacy. CVS is a large pharmacy chain in the United States
    • PRO Panorama

      Moneycontrol Pro Panorama | An advent calendar for markets

      Nov 14, 2025 / 03:20 PM IST

      In November 14 edition of Moneycontrol Pro Panorama: Is the gold rally a warning about inflation ahead, thematic schemes are boomi...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts